Financials Breakout

Financial Breakout

The Financial Sector gave us the breakout we had been waiting to happen, with the Financial Select Sector SPDR® ETF (XLF) moving up by almost 1.20 percent to $25.20. In my latest premium video, we discuss the breakout, and what means for the group going forward.

You can watch the video here:  Financials Breakout As We Expected

Technology

Technology continues to perform well, despite Alphabet (GOOGL) falling modestly today following its second quarter results. The Technology Select Sector SPDR® ETF (XLK), managed to eek out mostly flat day, despite Alphabet falling by around 3 percent.
XLK Price Chart

XLK Price data by YCharts

Let us write research for you! Find out more here.

Biotech

Biotech stocks fell modestly with the iShares Nasdaq Biotechnology ETF (IBB) lower by 1 percent dragged down for the most part by Biogen (BIIB) after reporting results that beat on the top and bottom while outlining a growth plan going forward.
IBB Price Chart

IBB Price data by YCharts

Free Articles By Mike

Ford 2Q Preview: Profits Going in Reverse

Exact Sciences Earnings OutLook: Not An Easy Task

Will Recent Health Scares Hurt Chipotle’s 2Q Results?

AMD Earnings Outlook: In-Line Won’t Be Good Enough

General Motors 2Q Earnings: What to Watch For

Why Coca-Cola Shares Are Overvalued

Disclaimer:

Michael Kramer and the clients of Mott Capital own Googl

Michael Kramer is the Founder of Mott Capital Management LLC, a registered investment adviser, and the manager of the company’s actively managed, long-only Thematic Growth Portfolio.  Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendations made during the past twelve months. Past performance is not indicative of future performance.